SPRINGFIELD, Mo. – One in nine women suffers from postpartum depression in the U.S.
It’s estimated that every year more than 400,000 babies are born to moms who are depressed.
The FDA has recently approved a drug to treat postpartum depression. This is the first drug that is specifically designed to treat this illness.
It’s called Brexanolone and will be sold as Zulresso. It would be administered through IV and is said to work within hours. But it’s still a new drug and there are some concerns with it, including how much it cost and side effects.
Jenifer Abreu talked to Dr. Gregory Stamps, an OB/GYN from CoxHealth about the new drug, but most importantly about postpartum depression itself.